Skip to main content

Together we are beating cancer

Donate now

Cancer News

Institute

Showing 12 out of 65 results

Today, we've announced TRACERx EVO, a new programme that builds on the discoveries made in the world’s largest long-term lung study, TRACERx.  Today, we've announced TRACERx EVO, a new programme that builds on the discoveries made in the world’s largest long-term lung study, TRACERx. 

by Kathryn Thompson | News | 9 November 2022

9 November 2022

A 3D illustration of cancer cells

Research from our Cambridge Institute has shown us that metastasis isn’t a process unique to cancer, revolutionising the way we think about cell dissemination.  Research from our Cambridge Institute has shown us that metastasis isn’t a process unique to cancer, revolutionising the way we think about cell dissemination. 

by Jacob Smith | Analysis | 18 October 2022

18 October 2022

A illustration of T cells, a type of immune cell attacking cancer

If we’re to reduce the risk of bowel cancer in people with IBD, we’re going to have to find a more effective treatment. And we may have done just that.  If we’re to reduce the risk of bowel cancer in people with IBD, we’re going to have to find a more effective treatment. And we may have done just that. 

by Jacob Smith | Analysis | 23 August 2022

23 August 2022

Dr Hugo De La Peña in front of University Hospital Southampton

Dr Hugo De La Peña, the face of our latest TV advert, explains how a second chance at life led to a career dedicated to curing cancer.   Dr Hugo De La Peña, the face of our latest TV advert, explains how a second chance at life led to a career dedicated to curing cancer.  

by Elisa Mitchell | Personal stories | 12 August 2022

12 August 2022

A photograph of a person holding a blood test

Our researchers at the University of Cambridge have found that patients who are at a higher risk of their lung cancer returning can be identified by a personalised blood test. Our researchers at the University of Cambridge have found that patients who are at a higher risk of their lung cancer returning can be identified by a personalised blood test.

by Graeme Sneddon | News | 1 April 2022

1 April 2022

Seb
  • Science & Technology
  • For Researchers

Embracing a full spectrum of researchers

For drug discovery scientist Sebastian Greenhough, a late diagnosis of autism made sense of several things – but something it certainly didn’t do was stand in the way of his research For drug discovery scientist Sebastian Greenhough, a late diagnosis of autism made sense of several things – but something it certainly didn’t do was stand in the way of his research

by Cancer Research UK | Analysis | 24 February 2022

24 February 2022

This entry is part 5 of 10 in the series Diversity in research
Vivian Li, group leader of the stem cell and cancer biology lab at the Francis Crick Institute

Disrupted cell signalling, hijacked stem cells and the power of 'mini-guts' – we hear from Dr Vivian Li on the challenges and opportunities of developing colorectal cancer treatments. Disrupted cell signalling, hijacked stem cells and the power of 'mini-guts' – we hear from Dr Vivian Li on the challenges and opportunities of developing colorectal cancer treatments.

by Phil Prime | In depth | 11 February 2022

11 February 2022

  • For Researchers
  • Science & Technology

Seven Centres to form new Cancer Research UK network

From 1 April, we’re investing £100 million over five years into seven Cancer Research UK Centres across the UK. From 1 April, we’re investing £100 million over five years into seven Cancer Research UK Centres across the UK.

by Cancer Research UK | In depth | 24 January 2022

24 January 2022